Treatment of Candidal Cholangitis with Caspofungin Therapy in a Patient with a Liver Transplant: Documentation of Biliary Excretion of Caspofungin
Open Access
- 1 April 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (7) , 1040-1041
Abstract
The decision to use caspofungin therapy in treating our patient was influenced by several factors, including initial concerns over the recent emergence of azoleKeywords
This publication has 6 references indexed in Scilit:
- In Vitro Activities of Caspofungin Compared with Those of Fluconazole and Itraconazole against 3,959 Clinical Isolates of Candida spp., Including 157 Fluconazole-Resistant IsolatesAntimicrobial Agents and Chemotherapy, 2003
- Safety and tolerability of caspofungin acetate in the treatment of fungal infectionsTransplant Infectious Disease, 2002
- Comparison of High-Performance Liquid Chromatographic and Microbiological Methods for Determination of Voriconazole Levels in PlasmaAntimicrobial Agents and Chemotherapy, 2000
- Reconstructive Surgery for Ischemic-Type Lesions at the Bile Duct Bifurcation After Liver TransplantationAnnals of Surgery, 1999
- Selection ofCandida glabrata strains with reduced susceptibility to azoles in four liver transplant patients with invasive candidiasisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Serum Level Determination of Fluconazole by High-performance Liquid Chromatography and BioassayZentralblatt für Bakteriologie, 1996